Reported total revenues of $21.2 million for Q1 2026, compared to $7.2 million in Q1 2025, driven by the addition of Pharmacy Services and expanded Healthcare Services operations. Net loss attributable to common stockholders was $1.2 million, or $0.29 per share, compared to a net loss of $1.9 million, or $0.94 per share, in the prior-year period. Operating expenses rose to $21.9 million from $7.5 million, reflecting the costs associated with the expanded operating platform. The company transitioned from a pure real estate landlord model to an integrated owner-operator model, now managing seven facilities directly. Cash and restricted cash totaled $4.1 million as of March 31, 2026.